Management of chromoblastomycosis: novel perspectives

Current Opinion in Infectious Diseases
Philippe Esterre, Flavio Queiroz-Telles

Abstract

Significant advances in knowledge of chromoblastomycosis and its etiologic agents have been made in the past 5 years. New explanations and approaches that could resolve persisting medical challenges for this orphan disease are reviewed here. In recent years advances have been made regarding the taxonomy and ecoepidemiology of the etiologic agents, basic knowledge of the pathogenesis of the lesions, especially the fibrotic process, and the immunologic response to chromoblastomycosis. Conversely there have been no recent significant advances in knowledge of the genetic polymorphism of the wild isolates or in development of experimental models, impairing the possibility of in-depth clinicopathologic investigations. As a result medical management is dependent on the development of diagnostic and therapeutic tools developed for other fungal diseases. Recent findings are applicable in laboratory and medical practice. Benefits can accrue to basic knowledge from data collected on other cutaneous diseases of parasitic or bacterial origin.

References

Oct 1, 1992·International Journal of Dermatology·L FrancoA Restrepo
Nov 1, 1991·Journal of the American Academy of Dermatology·R Pradinaud, T Bolzinger
Jan 1, 1989·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·L T TsunetoF Queiroz-Telles
Jan 1, 1993·Virchows Archiv. A, Pathological Anatomy and Histopathology·P EsterreJ A Grimaud
May 22, 1998·Journal of the American Academy of Dermatology·K C Hazen
May 9, 2000·Clinical and Diagnostic Laboratory Immunology·P EsterreA Andriantsimahavandy
Feb 24, 2001·Medical Mycology·G S De HoogF Yegres
Apr 26, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John R PerfectElizabeth Johnson
May 20, 2003·Infectious Disease Clinics of North America·Flavio Queiroz-TellesJohn R Graybill
May 21, 2003·International Journal of Dermatology·Luiz G M CastroCarlos S Lacaz
Aug 2, 2003·International Journal of Dermatology·Marília M OgawaJane Tomimori-Yamashita
Jan 30, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J A Maertens
Sep 1, 1950·Annals of the New York Academy of Sciences·A L CARRION
Mar 5, 2004·Expert Opinion on Pharmacotherapy·Alexandro BonifazAmado Saúl
Apr 2, 2004·Revista Do Instituto De Medicina Tropical De São Paulo·Claudio Guedes SalgadoUbirajara Imbiriba Salgado
Nov 24, 2004·Medical Mycology·G S De HoogF Queiroz-Telles
Apr 26, 2005·Microbes and Infection·Viviane Mazo Fávero GimenesSandro Rogério Almeida
May 18, 2005·The Journal of Dermatological Treatment·A BonifazL Fierro-Arias
Jul 22, 2005·Drugs·Gillian M Keating

❮ Previous
Next ❯

Citations

Jul 20, 2012·Current Infectious Disease Reports·Ricardo M La Hoz, John W Baddley
Dec 23, 2011·The Journal of Antimicrobial Chemotherapy·Enrique CalvoJosep Guarro
Nov 23, 2007·The American Journal of Dermatopathology·Ryan S JawitzMichael B Morgan
Sep 24, 2009·Current Opinion in Infectious Diseases·Marcia GarnicaFlavio Queiroz-Telles
Jan 21, 2010·Antimicrobial Agents and Chemotherapy·Mohammad J NajafzadehJacques F Meis
May 4, 2011·World Journal of Biological Chemistry·André Luis Souza Dos Santos
Feb 18, 2011·Mycopathologia·Katlein FrançaValcinir Bedin
Dec 17, 2008·Medical Mycology·Flavio Queiroz-TellesAlexandro Bonifaz
Sep 25, 2012·International Journal of Antimicrobial Agents·Luciana P RangelAntonio Ferreira-Pereira
Dec 21, 2010·Revista iberoamericana de micología·Víctor Fernando Muñoz EstradaMariana Rochín Tolosa
Nov 26, 2010·Journal of the American Academy of Dermatology·Peggy A WuAlexandra F Freeman
Mar 7, 2007·Diagnostic Microbiology and Infectious Disease·Tânia Sueli de AndradeRosario Dominguez Crespo Hirata
Aug 30, 2008·Journal of Cutaneous Pathology·Claudio G SalgadoJorge P da Silva
Mar 12, 2008·Journal of the European Academy of Dermatology and Venereology : JEADV·A TsianakasG Bonsmann
Apr 5, 2011·Transplant Infectious Disease : an Official Journal of the Transplantation Society·A Garcia-ReyneJ M Aguado
Jul 7, 2009·Clinical and Experimental Dermatology·M Ameen
Jul 25, 2007·FEMS Microbiology Reviews·André L S SantosCeluta S Alviano
Feb 15, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Conceição M P S AzevedoMaria A Resende-Stoianoff
Nov 18, 2014·Frontiers in Cellular and Infection Microbiology·Juliana R BurjackGuilherme L Sassaki
Nov 11, 2014·The Journal of Laryngology and Otology·D PenjorK T Wong
Oct 16, 2015·Revista Do Instituto De Medicina Tropical De São Paulo·Flavio Queiroz-Telles
Jul 4, 2017·International Journal of Dermatology·Max Carlos Ramírez Soto, German Malaga
Nov 20, 2016·Clinical Microbiology Reviews·Flavio Queiroz-TellesThomas J Walsh
Jul 2, 2014·Clinical Microbiology Reviews·Seyedmojtaba SeyedmousaviG Sybren de Hoog
Feb 18, 2011·Pediatric Annals·Robert S Gold
Oct 17, 2012·International Journal of Pharmaceutical Investigation·Swati SareenLincy Joseph
Dec 20, 2015·Medicine·Saad J Taj-AldeenUNKNOWN International Osteoarticular Mycoses Consortium
Jul 30, 2010·The Journal of Dermatological Treatment·Paulo Ricardo CriadoWalter Belda
May 3, 2013·Mycopathologia·Flavio Queiroz-Telles, Daniel Wagner de C L Santos
Oct 26, 2018·Frontiers in Microbiology·Gheniffer FornariSybren de Hoog
Mar 11, 2020·The Pan African Medical Journal·Sadia KhanKavitha Dinesh
Nov 17, 2020·Frontiers in Immunology·Leandro Carvalho Dantas BredaSandro Rogério de Almeida
Jul 14, 2010·Cytokine·Jorge Pereira da SilvaClaudio Guedes Salgado

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.